In the trial, published in the New England Journal of Medicine, angiodema symptoms were reduced by 95% among a small group of patients from the UK, New Zealand, and the Netherlands given a single infusion – targeted at cells in the liver – to reduce the KLKB1 gene’s ability to produce plasma prekallikrein.
Trending
- Here you can read everything about Charli XCX ‘unconventional wedding ring
- Mexx Spring Summer ‘26
- Dit gebeurt er met je lichaam als je op vakantie even niet sport
- 'My dad started spying on my mum' – the drugs causing sexual urges
- Bread producers Hovis and Kingsmill close in on historic merger | Money News
- Milei tames inflation, but Argentines still struggle to afford basics | Inflation
- Salon owner ‘ready’ for key L’Oréal trademark dispute hearing
- Global Wealth Report: Where in Europe did people’s net worth increase the most?
